Primary record
Orphenadrine citrate; (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate
- 库存
- 3,818 克
- 纯度
- 98.2 %
- CAS
- 4682-36-4
化合物标识与属性
- CAS
- 4682-36-4
- PubChem CID
- 83823
- SMILES
- CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
- Canonical SMILES
- Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
名称与同义词
- Orphenadrine citrate
- Norflex
- Banflex
- Flexon
- Flexoject
- Plenactol
- Euflex
- Flexor
- X-Otag
- 4682-36-4
- Benhexal
- Norgesic
- Tega-Flex
- Orphenadrine (Citrate)
- citrate
- Orphengesic
- Invagesic
- Orphenadrine citrate salt
- Norgesic forte
- Orphenadrine dihydrogen citrate
- Orphenadrinecitrate
- Invagesic Forte
- Mixture Name
- Orphengesic Forte
- citro; orphenadrine
- Norflex (pharmaceutical)
- Norflex (TN)
- Citrate, Orphenadrine
- Orphenadrine Citrate ER
- RefChem:55784
- Orphenadrine citrate CRS
- C24H31NO8
- Orphenadrine citrate (USP)
- Orphenadrine citrate [USP]
- UNII-X0A40N8I4S
- X0A40N8I4S
- Orphenadrine Citrate [USAN]
- DTXSID8044678
- AC1Q74TZ
- Orphenadrine citrate (Norflex)
- CHEBI:7790
- C18H23NO.C6H8O7
- DTXCID6024678
- MLS000069549
- NSC-757238
- SCHEMBL119470
- SPECTRUM1500447
- EINECS 225-137-5
- HY-B0369AR
- orb1300611
- CHEMBL1200395
- SCHEMBL29369316
- CTK7J1567
- ERK5-1L18
- HMS502K15
- HY-B0369A
- MSK14446X
- ORPHENADRINE CITRATE [MI]
- MMMNTDFSPSQXJP-UHFFFAOYSA-N
- HMS1920D10
- HMS2091L10
- HMS2231J06
- HMS3259M21
- HMS3370M12
- HMS3651A10
- HMS3884M22
- HMS5080H21
- Orphenadrine (citrate) (Standard)
- Pharmakon1600-01500447
- AC1L3690
- CID83823
- o-Methyldiphenhydramine citrate salt
- ORPHENADRINE CITRATE [VANDF]
- Tox21_111323
- Tox21_113543
- Tox21_301079
- AN-903
- CCG-40242
- EBC-11114
- MFCD00079197
- NCGC00094745-01
- NSC757238
- ORPHENADRINE CITRATE [MART.]
- ORPHENADRINE CITRATE [WHO-DD]
- AKOS008132385
- Tox21_111323_1
- CS-2426
- CS-O-10184
- FO26587
- NC00525
- NE62567
- NSC 757238
- 4596-23-0
- NCGC00015771-04
- NCGC00015771-13
- NCGC00094745-02
- NCGC00094745-03
- NCGC00254980-01
- AK117797
- AS-74807
- C18-H23-N-O.C6-H8-O7
- CPD000058817
- DA-66372
- ORPHENADRINE CITRATE [EP IMPURITY]
- ORPHENADRINE CITRATE [ORANGE BOOK]
- P008
- SAM002554918
- SAM002589900
- SMR000058817
- CAS-4682-36-4
- ORPHENADRINE CITRATE [EP MONOGRAPH]
- AB2000458
- LS-175025
- ORPHENADRINE CITRATE [USP MONOGRAPH]
- 2-hydroxypropane-1,2,3-tricarboxylic acid; dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine
- FT-0655842
- FT-0673305
- NS00082653
- S2054
- SW102176-4
- 4682-36-4, 83-98-7 [orphenadrine]
- EN300-53019
- NORGESIC COMPONENT ORPHENADRINE CITRATE
- C75247
- D00774
- INVAGESIC COMPONENT ORPHENADRINE CITRATE
- ORPHENGESIC COMPONENT ORPHENADRINE CITRATE
- A826945
- ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
- SR-01000002975
- I06-1758
- SR-01000002975-5
- 2-Dimethylaminoethyl-2-methyl-benzhydryl ether citrate
- INVAGESIC FORTE COMPONENT ORPHENADRINE CITRATE
- ORPHENGESIC FORTE COMPONENT ORPHENADRINE CITRATE
- Q27107584
- N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1)
- N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid
- Z234896463
- N,N-Dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate
- N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine
- N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine Citrate Salt
- citric acid; N,N-dimethyl-2-[o-tolyl(phenyl)methoxy]ethanamine
- Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid
- (+-)-N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1)
- BETA-DIMETHYLAMINOETHYL 2-METHYLBENZHYDRYL ETHER CITRATE SALT
- Ethylamine, N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)-, citrate (1:1)
- N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate
- (+-)-N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate
- Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, (+-)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- (+/-)-N,N-DIMETHYL-2-((O-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1)
- 3-carboxy-3,5-dihydroxy-5-oxo-pentanoate;dimethyl-[2-[o-tolyl(phenyl)methoxy]ethyl]ammonium
- N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate
- (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]- ethanamine dihydrogen 2-hydroxypropane-1,2,3- tricarboxylate
- 2-Hydroxypropane-1,2,3-tricarboxylic acid--N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethan-1-amine (1/1)
- 225-137-5
- 4724-58-7
- Etanamina, N,N-dimetil-2-[(2-metilfenil)fenilmetoxi]-, 2-hidroxi-1,2,3-propanotricarboxilato (1:1)
- Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenyl)methoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- ETHANAMINE, N,N-DIMETHYL-2-((2-METHYLPHENYL)PHENYLMETHOXY)-, (+/-)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
- Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1)
- N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine 2-hydroxypropane-1,2,3-tricarboxylate
- N,N-Dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine 2-hydroxypropane-1,2,3-tricarboxylic acid salt
- Orphenadrine citrate; (RS)-N,N-Dimethyl-2-[(2-methylphenyl)phenylmethoxy]ethanamine dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate